Report: Cancer drugs to experience double-digit sales growth

05/15/2008 | Yahoo!

Costly new treatments and increased use of targeted therapeutic agents in emerging markets will drive cancer drug sales to about $80 billion by 2012, according to the IMS Global Oncology Forecast issued Thursday. But the report also said that slumping sales of current best-sellers, financial constraints on payers and other factors could moderate market growth.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN